Caroline’s research is centered on healthcare technology innovation. Her dissertation studies the role of patients, foundations, and digital technology in shaping therapeutic development within the biopharmaceutical industry. Caroline’s current projects focus on two primary themes: quantifying the impact of rare disease patient foundations in accelerating drug development and measuring trends in the use of patient-focused, connected digital products within clinical research
Caroline graduated from Vanderbilt University in 2011 with a BS in Engineering and minors in Corporate Strategy and Engineering Management. She also holds a Master of Engineering Management with a concentration in Healthcare Systems from Dartmouth College. Prior to pursuing doctoral work, Caroline was a Manager at Clarion Healthcare, a life sciences strategy consulting firm based in Boston, where she led a range of scientific and commercially focused strategic assessments for pharmaceutical and biotechnology clients.